It is a pharma private limited company based in Thane West, Maharashtra, India, established in 2014.
2014 | Thane West, Maharashtra, India | ActiveMaxx Pharmaceuticals Private Limited, a active private limited company, was established on 25 July 2014 in Thane West, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24110MH2014PTC256572. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sandesh Pandurang Vaidya (Director), Pritee Yogesh Khandave (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 216-A, 2Nd Floor, Soham Plaza, Manpada Bus Stop, Chitalsar, G.B. Road,, Thane West, Maharashtra, 400607.
U24110MH2014PTC256572
256572
25 July 2014
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Maxx Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sandesh Pandurang Vaidya | Director | 25 Jul 2014 | Current |
| Pritee Yogesh Khandave | Director | 25 Jul 2014 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Maxx Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 952.8% increase. The company also saw a substantial improvement in profitability, with a 98.76% increase in profit. The company's net worth dipped by a decrease of 1.38%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Maxx Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Maxx Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Maxx Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxx Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Maxx Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Maxx Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Sandesh Pandurang Vaidya was appointed as a Director was appointed as a Director on 25 Jul 2014 & has been associated with this company since 11 years 5 months . was documented.
Pritee Yogesh Khandave was appointed as a Director was appointed as a Director on 25 Jul 2014 & has been associated with this company since 11 years 5 months . was recorded as a recent event.
Maxx Pharmaceuticals Private Limited was registered on 25 Jul 2014 with Roc Mumbai & aged 11 years 5 months as per MCA records. was recorded as a recent event.
The CIN of Maxx Pharmaceuticals Private Limited is U24110MH2014PTC256572.
Maxx Pharmaceuticals Private Limited is headquartered at 216-A, 2Nd Floor, Soham Plaza, Manpada Bus Stop, Chitalsar, G.B. Road,, Thane West, Maharashtra, 400607.
Maxx Pharmaceuticals Private Limited was incorporated on 25 July 2014.
The current directors of Maxx Pharmaceuticals Private Limited are
The primary industry of Maxx Pharmaceuticals Private Limited is Pharma.
Maxx Pharmaceuticals Private Limited is unlisted.
The authorized capital of Maxx Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Maxx Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX